Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Sold by LMR Partners LLP

LMR Partners LLP lessened its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 69.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,000 shares of the company's stock after selling 22,938 shares during the period. LMR Partners LLP's holdings in Establishment Labs were worth $433,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Capital Research Global Investors acquired a new position in Establishment Labs in the first quarter worth $45,888,000. Rice Hall James & Associates LLC grew its position in shares of Establishment Labs by 10.7% during the 3rd quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company's stock valued at $34,326,000 after buying an additional 76,959 shares during the last quarter. William Blair Investment Management LLC raised its stake in Establishment Labs by 14.5% during the second quarter. William Blair Investment Management LLC now owns 481,572 shares of the company's stock worth $21,883,000 after acquiring an additional 60,848 shares during the period. Bamco Inc. NY lifted its holdings in Establishment Labs by 28.4% in the first quarter. Bamco Inc. NY now owns 429,775 shares of the company's stock worth $21,876,000 after acquiring an additional 95,000 shares during the last quarter. Finally, Sofinnova Investments Inc. boosted its stake in Establishment Labs by 204.1% in the second quarter. Sofinnova Investments Inc. now owns 429,244 shares of the company's stock valued at $19,505,000 after acquiring an additional 288,082 shares during the period. Institutional investors and hedge funds own 72.91% of the company's stock.

Establishment Labs Price Performance

ESTA stock traded up $4.29 during trading on Wednesday, hitting $41.81. The company had a trading volume of 996,952 shares, compared to its average volume of 389,323. The business has a 50 day moving average of $42.95 and a 200 day moving average of $45.36. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of -15.53 and a beta of 1.20. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a fifty-two week low of $21.25 and a fifty-two week high of $60.12.

Analyst Ratings Changes

Several brokerages recently issued reports on ESTA. BTIG Research raised their price target on Establishment Labs from $62.00 to $65.00 and gave the stock a "buy" rating in a report on Monday, October 14th. JPMorgan Chase & Co. reduced their price target on shares of Establishment Labs from $61.00 to $50.00 and set an "overweight" rating for the company in a report on Wednesday, August 7th. Citigroup increased their price objective on shares of Establishment Labs from $45.00 to $50.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st. Finally, Stephens reissued an "overweight" rating and set a $68.00 target price on shares of Establishment Labs in a research note on Wednesday, August 7th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $60.60.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.